{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T14:21:59Z","timestamp":1777040519950,"version":"3.51.4"},"reference-count":43,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2013,12,23]],"date-time":"2013-12-23T00:00:00Z","timestamp":1387756800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0083075","type":"journal-article","created":{"date-parts":[[2013,12,23]],"date-time":"2013-12-23T22:10:48Z","timestamp":1387836648000},"page":"e83075","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":18,"title":["Decrease in Formalin-Inactivated Respiratory Syncytial Virus (FI-RSV) Enhanced Disease with RSV G Glycoprotein Peptide Immunization in BALB\/c Mice"],"prefix":"10.1371","volume":"8","author":[{"given":"Gertrud U.","family":"Rey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Congrong","family":"Miao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hayat","family":"Caidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suvang U.","family":"Trivedi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer L.","family":"Harcourt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralph A.","family":"Tripp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larry J.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lia M.","family":"Haynes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2013,12,23]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1056\/NEJMoa0804877","article-title":"The burden of respiratory syncytial virus infection in young children","volume":"360","author":"CB Hall","year":"2009","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S0140-6736(10)60206-1","article-title":"Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis","volume":"375","author":"H Nair","year":"2010","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1093\/oxfordjournals.aje.a120957","article-title":"Field evaluation of a respiratory syncytial virus vaccine and a trivalent parainfluenza virus vaccine in a pediatric population","volume":"89","author":"J Chin","year":"1969","journal-title":"Am J Epidemiol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1093\/oxfordjournals.aje.a120956","article-title":"Respiratory virus immunization: I. A field of two inactivated respiratory virus vaccines; an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine","volume":"89","author":"VA Fulginiti","year":"1969","journal-title":"Am J Epidemiol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/oxfordjournals.aje.a120954","article-title":"An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine","volume":"89","author":"AZ Kapikian","year":"1969","journal-title":"Am J Epidemiol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/oxfordjournals.aje.a120955","article-title":"Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine","volume":"89","author":"HW Kim","year":"1969","journal-title":"Am J Epidemiol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"6935","DOI":"10.1128\/JVI.71.9.6935-6939.1997","article-title":"Priming with live respiratory syncytial virus (RSV) prevents enhanced pulmonary inflammatory responses associated with formalin inactivated RSV immunization in BALB\/c mice","volume":"71","author":"ME Waris","year":"1997","journal-title":"J Virol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1513\/pats.200501-011AW","article-title":"New generation live vaccines against human respiratory syncytial virus designed by reverse genetics","volume":"2","author":"PL Collins","year":"2005","journal-title":"Proc Am Thorac Soc"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/S0264-410X(97)00002-9","article-title":"Safety and immunogenicity of a respiratory syncytial virus subunit vaccine (PFP-2) in the institutionalized elderly","volume":"15","author":"AR Falsey","year":"1997","journal-title":"Vaccine"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1086\/592168","article-title":"Comparison of the safety and immunogenicity of 2 respiratory syncytial virus (RSV) vaccines--nonadjuvanted vaccine or vaccine adjuvanted with alum--given concomitantly with influenza vaccine to high-risk elderly individuals","volume":"198","author":"AR Falsey","year":"2008","journal-title":"J Infect Dis"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1097\/00006454-199409000-00008","article-title":"Safety and immunogenicity of a subunit respiratory syncytial virus vaccine in children 24 to 48 months old","volume":"13","author":"PR Paradiso","year":"1994","journal-title":"Pediatr Infect Dis J"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1086\/425981","article-title":"Evaluation of combined live, attenuated respiratory syncytial virus and parainfluenza 3 virus vaccines in infants and young children","volume":"190","author":"RB Belshe","year":"2004","journal-title":"J Infect Dis"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1086\/427813","article-title":"Identification of a recombinant live attenuated respiratory syncytial virus vaccine candidate that is highly attenuated in infants","volume":"191","author":"RA Karron","year":"2005","journal-title":"J Infect Dis"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"5667","DOI":"10.1016\/j.vaccine.2009.07.022","article-title":"Codon stabilization analysis of the "248" temperature sensitive mutation for increased phenotypic stability of respiratory syncytial virus vaccine candidates","volume":"27","author":"C Luongo","year":"2009","journal-title":"Vaccine"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"8446","DOI":"10.1128\/JVI.78.16.8446-8454.2004","article-title":"Characterization of recombinant respiratory syncytial viruses with the region responsible for type 2 T-cell responses and pulmonary eosinophilia deleted from the attachment (G)","volume":"78","author":"MB Elliott","year":"2004","journal-title":"J Virol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1128\/JVI.72.4.2871-2880.1998","article-title":"Priming with secreted glycoprotein G of respiratory syncytial virus (RSV) augments interleukin-5 production and tissue eosinophilia after RSV challenge","volume":"72","author":"TR Johnson","year":"1998","journal-title":"J Virol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1084\/jem.187.11.1921","article-title":"Eliminating a region of respiratory syncytial virus attachment allows induction of protective immunity without vaccine-enhanced lung eosinophilia","volume":"187","author":"TE Sparer","year":"1998","journal-title":"J Exp Med"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1084\/jem.188.10.1967","article-title":"Atypical pulmonary eosinophilia is mediated by a specific amino acid sequence of the attachment (G) of respiratory syncytial virus","volume":"188","author":"PW Tebbey","year":"1998","journal-title":"J Exp Med"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"7099","DOI":"10.1128\/JVI.73.9.7099-7107.1999","article-title":"Respiratory syncytial virus G and\/or SH alters Th1 cytokines, natural killer cells, and neutrophils responding to pulmonary infection in BALB\/c mice","volume":"73","author":"RA Tripp","year":"1999","journal-title":"J Virol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/90675","article-title":"CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein","volume":"2","author":"RA Tripp","year":"2001","journal-title":"Nat Immunol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"6227","DOI":"10.1128\/JVI.74.13.6227-6229.2000","article-title":"Respiratory syncytial virus G and\/or SH glycoprotein modify CC and CXC chemokine expression in the BALB\/c mouse","volume":"74","author":"RA Tripp","year":"2000","journal-title":"J Virol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1128\/JVI.74.4.1614-1622.2000","article-title":"Respiratory syncytial virus infection and G and\/or SH expression contribute to substance P, which mediates inflammation and enhanced pulmonary disease in BALB\/c mice","volume":"74","author":"RA Tripp","year":"2000","journal-title":"J Virol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"6580","DOI":"10.1128\/JVI.77.11.6580-6584.2003","article-title":"Respiratory syncytial virus depresses respiratory rates through the G glyco CX3C motif and substance P","volume":"77","author":"RA Tripp","year":"2003","journal-title":"J Virol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"9632","DOI":"10.1128\/JVI.00451-10","article-title":"Prophylactic treatment with a G glycoprotein monoclonal antibody reduces pulmonary inflammation in respiratory syncytial virus (RSV)-challenged naive and formalin-inactivated RSV-immunized BALB\/c mice","volume":"84","author":"GU Radu","year":"2010","journal-title":"J Virol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"9831","DOI":"10.1128\/JVI.77.18.9831-9844.2003","article-title":"Enhanced disease and pulmonary eosinophilia associated with formalin-inactivated respiratory syncytial virus vaccination are linked to G glycoprotein CX3C-CX3CR1 interaction and expression of substance P","volume":"77","author":"LM Haynes","year":"2003","journal-title":"J Virol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1086\/600108","article-title":"Therapeutic Monoclonal Antibody Treatment Targeting Respiratory Syncytial Virus (RSV) G Mediates Viral Clearance and Reduces the Pathogenesis of RSV Infection in BALB\/c Mice","volume":"200","author":"LM Haynes","year":"2009","journal-title":"J Infect Dis"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/BF01310492","article-title":"Synthetic peptides corresponding to the F of RSV stimulate murine B and T cells but fail to confer protection","volume":"117","author":"M Trudel","year":"1991","journal-title":"Arch Virol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"4232","DOI":"10.1128\/JVI.62.11.4232-4238.1988","article-title":"Neutralization of respiratory syncytial virus by individual and mixtures of F and G monoclonal antibodies","volume":"62","author":"LJ Anderson","year":"1988","journal-title":"J Virol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1128\/JVI.01755-09","article-title":"Vaccination to induce antibodies blocking the CX3C-CX3CR1 interaction of respiratory syncytial virus G reduces pulmonary inflammation and virus replication in mice","volume":"84","author":"W Zhang","year":"2010","journal-title":"J Virol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1086\/314778","article-title":"Protective efficacy agains respiratory syncytial virus following murine neonatal immunization with BBG2Na vaccine: influence of adjuvants and maternal antibodies","volume":"179","author":"CA Siegrist","year":"1999","journal-title":"J Infect Dis"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jcv.2007.10.024","article-title":"Respiratory syncytial virus (RSV) vaccines: two steps back for one leap forward","volume":"41","author":"UF Power","year":"2008","journal-title":"J Clin Virol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"7783","DOI":"10.1128\/JVI.70.11.7783-7791.1996","article-title":"Generation of atypical pulmonary inflammatory responses in BALB\/c mice after immunization with the native attachment (G) glyco of respiratory syncytial virus","volume":"70","author":"GE Hancock","year":"1996","journal-title":"J Virol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1099\/vir.0.009308-0","article-title":"Treatment with respiratory syncytial virus G glycoprotein monoclonal antibody or F(ab')2 components mediates reduced pulmonary inflammation in mice","volume":"90","author":"C Miao","year":"2009","journal-title":"J Gen Virol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"7444","DOI":"10.1128\/JVI.66.12.7444-7451.1992","article-title":"Pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB\/c mice is abrogated by depletion of CD4+ T cells","volume":"66","author":"M Connors","year":"1992","journal-title":"J Virol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.4049\/jimmunol.151.4.2032","article-title":"Priming immunization determines T helper cytokine mRNA expression patterns in lungs of mice challenged with respiratory syncytial virus","volume":"151","author":"BS Graham","year":"1993","journal-title":"J Immunol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"6024","DOI":"10.1128\/JVI.78.11.6024-6032.2004","article-title":"Respiratory syncytial virus (RSV) G glyco is not necessary for vaccine-enhanced disease induced by immunization with formalin-inactivated RSV","volume":"78","author":"TR Johnson","year":"2004","journal-title":"J Virol"},{"key":"ref37","first-page":"721","article-title":"Enhancement of respiratory syncytial virus pulmonary pathology in cotton rats by prior intramuscular inoculation of formalin-inactivated virus [published erratum appears in J Virol 1986;59:193]","volume":"57","author":"GA Prince","year":"1986","journal-title":"J Virol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1128\/JVI.70.5.2852-2860.1996","article-title":"Respiratory syncytial virus infection in BALB\/c mice previously immunized with formalin-inactivated virus induces enhanced pulmonary inflammatory response with a Th2-like cytokine pattern","volume":"70","author":"ME Waris","year":"1996","journal-title":"J Virol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/nm1456","article-title":"A potential molecular mechanism for hypersensitivity caused by formalin-inactivated vaccines","volume":"12","author":"A Moghaddam","year":"2006","journal-title":"Nat Med"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s10156-002-0178-6","article-title":"Development and use of palivizumab (Synagis): a passive immunoprophylactic agent for RSV","volume":"8","author":"P Pollack","year":"2002","journal-title":"J Infect Chemother"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1128\/JVI.01861-10","article-title":"Assembly and immunological properties of Newcastle disease virus-like particles containing the respiratory syncytial virus F and G s","volume":"85","author":"LW McGinnes","year":"2011","journal-title":"J Virol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"4804","DOI":"10.4049\/jimmunol.1000484","article-title":"Immunomodulation with IL-4R\u03b1 antisense oligonucleotide prevents respiratory syncytial virus-mediated pulmonary disease","volume":"185","author":"MJ Ripple","year":"2010","journal-title":"J Immunol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"5543","DOI":"10.1016\/j.vaccine.2010.06.041","article-title":"Lipopeptide-adjuvanted respiratory syncytial virus virosomes: A safe and immunogenic non-replicating vaccine formulation","volume":"28","author":"T Stegmann","year":"2010","journal-title":"Vaccine"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0083075","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,9]],"date-time":"2023-07-09T08:18:51Z","timestamp":1688890731000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0083075"}},"subtitle":[],"editor":[{"given":"Steven\u00a0M.","family":"Varga","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,12,23]]},"references-count":43,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2013,12,23]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0083075","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,23]]}}}